Boston Scientific BSX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 275%+0.5pp | 274.5%+0.4pp | 274.1%-0.4pp | 274.5%-0.7pp | 275.2%-0.6pp | |
| Operating margin | 71.3%+2.2pp | 69.1%+2.5pp | 66.7%+2.1pp | 64.6%+0.8pp | 63.8%-0.5pp | |
| Net margin | 59.6%+5.7pp | 53.8%+3.4pp | 50.4%+3.2pp | 47.3%+1.5pp | 45.8%-0.5pp | |
| Returns | ||||||
| Return on equity | 51.7%+5.2pp | 46.5%+3.6pp | 42.9%+3.6pp | 39.3%+2.2pp | 37.1%+0.2pp | |
| Efficiency | ||||||
| Asset turnover | 1.9×0.0× | 1.9×0.0× | 1.9×0.0× | 1.8×0.0× | 1.8×0.0× | |
| Liquidity | ||||||
| Current ratio | 6.4×+0.4× | 5.9×+0.5× | 5.4×0.0× | 5.4×-0.2× | 5.6×-0.2× | |
| Per Share | ||||||
| Book value per share | $64.17+3.9% | $61.74+2.6% | $60.18+2.9% | $58.46+2.2% | $57.18+2.6% | |
| Valuation | ||||||
| Market capitalization | $533.31B-9.5% | $589.26B+1.7% | $579.55B+3.8% | $558.3B+7.9% | $517.48B+10.4% | |
| Price / earnings | 188.7×-47.5× | 236.2×-22.5× | 258.7×-17.1× | 275.8×-0.4× | 276.2×+16.9× | |
| Price / sales | 27.4×-4.0× | 31.3×-0.8× | 32.2×-0.3× | 32.4×+0.9× | 31.6×+1.7× | |
| Price / book | 22.5×-3.1× | 25.6×-0.2× | 25.8×+0.2× | 25.6×+1.3× | 24.3×+1.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Boston Scientific's profit margins?
- Boston Scientific (BSX) runs a 69.2% gross margin and a 18.4% operating margin, with a 17.3% net margin.
- Where do Boston Scientific's ratios come from?
- Every ratio is computed from Boston Scientific's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
